|
Bioniche Life Sciences Inc. is a leading, fully-integrated biopharmaceutical company that discovers, develops, manufactures, and markets proprietary products for human and animal health markets worldwide.
Media Coverage
For recent media coverage of Bioniche Life Sciences Inc. click here >>
Latest News
January 29, 2010
Bioniche E. coli O157 Vaccine Recognized in Prestigious Scientific Journal
more...
November 25, 2009
Bioniche Strengthens the International Patent Portfolio for its MCC Technology Platform
more...
November 6, 2009
Bioniche Reports Fiscal 2010 First Quarter Results And Achievement of First Milestone Under Licensing Agreement
more...
More News
|

Bioniche Key Facts
Founded: 1979
Chairman, President & CEO: Graeme McRae
TSX stock symbol: BNC
Fiscal year-end: June 30
2008 revenues:
C$27.7 million
Headquarters: Belleville, Ontario
Employees worldwide:
200
Business divisions: Human Health, Animal Health, Food Safety
Focus areas: Human Health:
cancer, immunomodulation
Animal Health: reproduction,
vaccines, replacement of antibiotics
Food Safety: E. coli O157 vaccine, other veterinary biopharmaceutical products to address diseases in livestock which may have an effect on human health
Top products:
Animal Health: Folltropin®-V, MAP®-5
|